home / stock / axdx / axdx articles
Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share c...
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) shares are trading lower by 38% to $1.00 during Friday’s session after the company priced an under...
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Friday. Following the market opening Friday, the Do...
News, Short Squeeze, Breakout and More Instantly...
Accelerate Diagnostics Inc. Company Name:
AXDX Stock Symbol:
NASDAQ Market:
Accelerate Diagnostics Inc. Website:
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results PR Newswire TUCSON, Ariz. , March 28, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and year ended ...
Swire Pacific Ltd. ADR (Class A) (SWRAY) is expected to report for Q4 2023 Troika Media Group Inc. (TRKAQ) is expected to report for quarter end 2023-12-31 American Environmental Partners Inc. (AEPT) is expected to report for quarter end 2023-12-31 Veolia Environnement S.A. ADR (VEOEY...
Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results. PR Newswire TUCSON, Ariz. , March 7, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thurs...